Status:

NOT_YET_RECRUITING

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Lead Sponsor:

Peking University Third Hospital

Conditions:

Locally Advanced Pancreatic Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This trial is designed to investigate the efficacy and safety of patients with locally advanced pancreatic cancer by SBRT combined with Zimberelimab(GLS-010).

Detailed Description

This a prospective, single-arm, multicenter study evaluating the efficacy and safety of stereotactic radiotherapy (SBRT) and Zimberelimab(GLS-010) in patients with pancreatic cancer. The primary endpo...

Eligibility Criteria

Inclusion

  • 18-75 years old.
  • Locally advanced pancreatic cancer confirmed histologically and defined according to the NCCN Pancreatic Cancer Guidelines v1.2022 as unresectable or surgically declined.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
  • The expected survival ≥ 3 months.
  • At least one tumor lesion meeting measurable disease criteria as determined by RECIST v1.1.
  • Patient must have adequate organ function defined by the study-specified laboratory tests.

Exclusion

  • Tumor invasion of the gastrointestinal tract, specifically pancreatic tumor or lymph node metastasis invading the gastrointestinal parenchyma.
  • Woman who are pregnant or breastfeeding.
  • Has a known additional malignancy within the past 5 years, except for cured skin cancer and cervical carcinoma in situ.
  • Patients who have received prior treatment with anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4, or with an agent directed to another stimulatory or co-inhibitory T-cell receptor.
  • Contraindications to immunotherapy.
  • Other conditions that investigator decides not suitable for the trial.

Key Trial Info

Start Date :

August 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2027

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT06009029

Start Date

August 1 2023

End Date

July 1 2027

Last Update

August 24 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.